Denali Therapeutics
DNLI
DNLI
114 hedge funds and large institutions have $1.6B invested in Denali Therapeutics in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14% more capital invested
Capital invested by funds: $1.41B → $1.6B (+$197M)
0.75% more ownership
Funds ownership: 71.72% → 72.48% (+0.75%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
114
Holding in Top 10
3
Calls
$48K
Puts
$2K
Top Buyers
| 1 | +$18M | |
| 2 | +$13.4M | |
| 3 | +$5.88M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.05M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.51M |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$5.81M | |
| 3 | -$3.69M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$2.97M |
| 5 |
CANY
Caxton Associates (New York)
New York
|
-$2.77M |